Target Name: ZNF75CP
NCBI ID: G729944
Review Report on ZNF75CP Target / Biomarker Content of Review Report on ZNF75CP Target / Biomarker
ZNF75CP
Other Name(s): ZNF75C | Zinc finger protein 75C, pseudogene | zinc finger protein 75C, pseudogene

ZNF75CP: A Potential Drug Target for Cell Proliferation and Development

ZNF75CP (ZNF75C), also known as Wnt-10c, is a protein that is expressed in various tissues throughout the body. It is a key regulator of the Wnt signaling pathway, which is a critical regulator of cell proliferation and development. ZNF75CP has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The Wnt signaling pathway is a critical regulator of cell proliferation and development. It is a trans-membrane signaling pathway that is involved in the regulation of cell proliferation, differentiation, and survival. The pathway is composed of several proteins, including Wnt-1, Wnt-2, and Wnt-3. Wnt-1 and Wnt-2 are involved in the regulation of cell growth and differentiation, while Wnt-3 is involved in the regulation of stem cell proliferation.

ZNF75CP is a key regulator of the Wnt signaling pathway. It is a trans-membrane protein that is involved in the regulation of the Wnt-1 and Wnt-2 proteins. ZNF75CP functions as a negative regulator of Wnt-1, which means that it prevents Wnt-1 from functioning as a signaling molecule. ZNF75CP does this by binding to the Wnt-1 protein and preventing it from interacting with its downstream target, the transcription factor SMAD.

ZNF75CP has been shown to be involved in the regulation of various physiological processes, including stem cell proliferation, tissue repair, and cancer development. It has been shown to play a role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has also been shown to be involved in the regulation of cancer cell growth and survival, which could make it an attractive drug target for cancer therapies.

In addition to its involvement in the regulation of the Wnt signaling pathway, ZNF75CP has also been shown to be involved in the regulation of other signaling pathways. It has been shown to be involved in the regulation of the TGF-β pathway, which is involved in the regulation of cell growth and differentiation. It has also been shown to be involved in the regulation of the Hedgehog pathway, which is involved in the regulation of cell proliferation and survival.

ZNF75CP has also been shown to be involved in the regulation of cellular processes that are important for tissue repair and regeneration. It has been shown to play a role in the regulation of cell proliferation and differentiation in various tissues, including the liver, heart, and nervous system. It has also been shown to be involved in the regulation of the production of extracellular matrix (ECM) components, which are important for tissue repair and regeneration.

In conclusion, ZNF75CP is a protein that is involved in the regulation of various signaling pathways that are important for cell proliferation and development. Its involvement in the regulation of the Wnt signaling pathway makes it an attractive drug target for diseases that are characterized by abnormal cell proliferation, such as cancer and neurodegenerative diseases. Further research is needed to fully understand the role of ZNF75CP in these diseases and to develop effective therapies that target this protein.

Protein Name: Zinc Finger Protein 75C, Pseudogene

Functions: May be involved in transcriptional regulation

The "ZNF75CP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF75CP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1